All In Biotech

Drug Trial Radar · NCT05514106

MIBG in Aging and Neurologic Disorders

Myocardial 123I-MIBG Scintigraphy in Aging and Neurodegenerative Disease

Last checked: Nov 20, 2026Latest source record: Jul 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

50

Planned (sponsor's estimate)

Start

May 8, 2023

Primary completion

Sep 2027

Study completion Sep 2027

Sponsor

Lead sponsor
Mayo ClinicAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 24, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated drug
No
Who can join
All sexes, from 40 years, up to 90 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of the study is to investigate the use of a special radioactive drug called 123I-MIBG and myocardial MIBG scintigraphy. This scan may be able to help determine who may have a certain kind of neurologic disorder called Lewy Body Disease. The overall purpose of this study is to correlate myocardial MIBG scintigraphy findings with clinical diagnosis. Myocardial MIBG scintigraphy imaging will be combined with other clinical, neuropsychological and neuroimaging findings to improve the prediction for underlying Lewy Body Disease.

Conditions

  • Lewy Body Disease
  • Dementia
  • Parkinsonism
  • Mild Cognitive Impairment
  • REM Sleep Behavior Disorder

Interventions

  • meta-iodobenzylguanidine (MIBG) (123I)Drug

    1 administration of 123I-MIBG for a single SPECT scan

  • 123I-MIBG scintigraphyDiagnostic test

    SPECT scan involving 123I-MIBG as the ligand

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Correlate myocardial 123I-MIBG scintigraphy findingsTime frame: 10 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Mayo Clinic in Rochester

    Rochester, Minnesota

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.